PDA Adopts Projects to Assist Pharma Manufacturers

BETHESDA, Md., Oct. 19, 2018 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) is pleased to announce the formation of a PDA technical report team and a task force to advance projects to assist pharmaceutical manufacturers in key areas. Both projects were approved by the PDA Science Advisory Board and have spun out of PDA's umbrella Manufacturing Science and Operations Program(SM), which is an advisory body to PDA of leading experts in pharmaceutical manufacturing.

The technical report team has been sanctioned to draft industry guidance on the governance and control of big data implementation in manufacturing enterprise to ensure maximization of data insights.

The task force will examine predictive maintenance of equipment utilizing advanced statistical and mathematical methodology. This task force could produce a written case study in the form of a PDA technical report, journal article or other publication type.

"PDA is pleased to sponsor these important projects that will support pharmaceutical manufacturers throughout the industry," said Richard Johnson, PDA President & CEO. "These are just the first of many projects PDA anticipates initiating in consultation with the MSOP advisory panel."

Both projects are part of the overarching PDA/MSOP Manufacturing Intelligence Task Force, co-chaired by Michele D'Allessandro, Merch VP & CIO, and Aaron Goerke, Head of Manufacturing Science and Technology, Roche Singapore Technical Operations.

###

About PDA ? Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

SOURCE The Parenteral Drug Association (PDA)